NANO NUCLEAR ENERGY INC.

EDGAR

Market value

$595.51M

53,698,146 shares as of 2026-08-10, at $11.09 a share (NNE, IEX close on 2026-11-12) Primary-source evidence

17 filing records in this dataset, filed from 2024-03-19 to 2026-08-12. Reported financial figures are available; chart coverage varies by period.

Watchlist

Holdings and insider activity

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, over the last 12 months.

Window: transactions dated on or after 2025-11-18.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
102 transactions, 6,127,145 shares
Sum of shares × price per share: 177,991,495.0383

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

  • 2026-10-01 Law Tsun Yee A 9,536 0
  • 2026-10-01 Hare Diane Elizabeth A 9,536 0
  • 2026-10-01 Walker James John A 257,790 0
  • 2026-10-01 Yu Kenny Joe Yung A 9,536 0
  • 2026-10-01 Berl Seth Jason A 9,536 0

5% holders (Schedule 13D and 13G)

  • Van Eck Associates Corporation 5.7% SCHEDULE 13G/A 09/30/2026
  • Van Eck Associates Corporation 7.3% SCHEDULE 13G/A 06/30/2026
  • BlackRock, Inc. 6.5% SCHEDULE 13G/A 06/30/2026

See all insider transactions

Latest quarter

Revenue

214 thousand USD

2026 Q3 · USD

Exact inputs and evidence

Operating margin

-7,393.69%

2026 Q3 · %

Exact inputs and evidence
  • Operating Income: -15825608 USD Source
  • Revenue: 214042 USD Source

Operating cash flow

-9.41 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -18664484 USD Source
  • Operating Cash Flow: -9254201 USD Source

Free cash flow

-10.5 million USD

2026 Q3 · USD

Exact inputs and evidence
  • Operating Cash Flow: -18664484 USD Source
  • Operating Cash Flow: -9254201 USD Source
  • Capital Expenditure: 9827509 USD Source
  • Capital Expenditure: 8760211 USD Source
Cash and cash equivalents
298 million USD Source
Exact value

298471607 USD

Long-term debt including current maturities
Not available
Shares outstanding
53.7 million shares Source
Exact value

53698146 shares

Reported share-count change

29.27% · 12.2 million shares

Year-over-year change in reported shares. Splits, issuance and buybacks can affect this figure; it does not isolate employee compensation or economic dilution.

Exact inputs and evidence
  • 41538323 shares · 2025-06-30· Source
  • 53698146 shares · 2026-06-30· Source

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Net income

-33.9 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Net income: -40067076 USD · 2024-10-01 – 2025-09-30 Source
  • Net income: -32016666 USD · 2024-10-01 – 2025-06-30 Source
  • Net income: -6516279 USD · 2025-10-01 – 2025-12-31 Source
  • Net income: -9180166 USD · 2026-01-01 – 2026-03-31 Source
  • Net income: -10104135 USD · 2026-04-01 – 2026-06-30 Source

Operating cash flow

-23.6 million USD

2025-07-01 – 2026-06-30

Exact inputs and evidence
  • Operating cash flow: -19621963 USD · 2024-10-01 – 2025-09-30 Source
  • Operating cash flow: -14713509 USD · 2024-10-01 – 2025-06-30 Source
  • Operating cash flow: -3989840 USD · 2025-10-01 – 2025-12-31 Source
  • Operating cash flow: -9254201 USD · 2025-10-01 – 2026-03-31 Source
  • Operating cash flow: -3989840 USD · 2025-10-01 – 2025-12-31 Source
  • Operating cash flow: -18664484 USD · 2025-10-01 – 2026-06-30 Source
  • Operating cash flow: -9254201 USD · 2025-10-01 – 2026-03-31 Source

Company performance

Up to ten complete financial years · consolidated figures

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2026-08-12.

Financial data available through: 2025-09-30.

Coverage by financial measure
  • revenue: No compatible figures in this window
  • Operating income: 1 of 11 periods available· newest 2023-09-30
  • Net income: 3 of 11 periods available· newest 2025-09-30
  • Operating cash flow: 3 of 11 periods available· newest 2025-09-30
  • Capital expenditure: 2 of 11 periods available· newest 2025-09-30
  • Total assets: 3 of 11 periods available· newest 2025-09-30
  • Total liabilities: 3 of 11 periods available· newest 2025-09-30
  • Current assets: 3 of 11 periods available· newest 2025-09-30
  • Current liabilities: 3 of 11 periods available· newest 2025-09-30
  • Cash and cash equivalents: 2 of 11 periods available· newest 2025-09-30
  • long term debt: No compatible figures in this window
  • Shares outstanding: 3 of 11 periods available· newest 2025-09-30

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

  • Net income

    −USD 29.92 million

    Prior period

    −USD 10.15 million

    –

    Current period

    −USD 40.07 million

    –

    Exact inputs and evidence

    -40067076 − -10151556 = -29915520 USD

    -10151556 USD · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -40067076 USD · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Operating cash flow

    −USD 11.16 million

    Prior period

    −USD 8.46 million

    –

    Current period

    −USD 19.62 million

    –

    Exact inputs and evidence

    -19621963 − -8464146 = -11157817 USD

    -8464146 USD · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    -19621963 USD · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

  • Capital expenditure

    +397%

    Prior period

    USD 1.7 million

    –

    Current period

    USD 8.45 million

    –

    Exact inputs and evidence

    8449332 − 1700000 = 6749332 USD

    1700000 USD · 2023-10-01 – 2024-09-30

    Inspect prior input Prior source

    8449332 USD · 2024-10-01 – 2025-09-30

    Inspect current input Current source
    Share or cite

    The citation records this snapshot. The page link may show a newer release later.

Comparable inputs unavailable for: Revenue.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

Revenue is not reported for this company, so its costs cannot be shown as a share of it.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

Not enough comparable data to show this history.
Values and sources
Revenue values and source evidence
PeriodSeriesValueSource evidence

Revenue growth

Change in revenue from the same financial period one year earlier.

Not enough comparable data to show this history.
Values and sources
Revenue growth values and source evidence
PeriodSeriesValueSource evidence

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Not enough comparable data to show this history.
  • Operating margin
  • Net margin
  • Free cash flow margin
Values and sources
Profit margins values and source evidence
PeriodSeriesValueSource evidence

Operating cash flow

Cash generated by the company’s normal business operations.

Not enough comparable data to show this history.
Values and sources
Operating cash flow values and source evidence
PeriodSeriesValueSource evidence

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

Not enough comparable data to show this history.
Values and sources
Free cash flow values and source evidence
PeriodSeriesValue(USD)Source evidence

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.
Values and sources
Liabilities to assets values and source evidence
PeriodSeriesValueSource evidence

Current assets to current liabilities

Current assets divided by current liabilities.

Not enough comparable data to show this history.
Values and sources
Current assets to current liabilities values and source evidence
PeriodSeriesValueSource evidence

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
PeriodNet incomeOperating cash flowCapital expenditureFree cash flow
2023 2022-10-01 – 2023-09-30
−USD 6.25 million
Exact value

Exact value: -6250401 USD

2022-10-01 – 2023-09-30: -6250401 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 3.87 million
Exact value

Exact value: -3867573 USD

2022-10-01 – 2023-09-30: -3867573 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

Unavailable Not reported for this period.
Unavailable

Free cash flow cannot be calculated because Capital expenditure is unavailable for this period.

2024 2023-10-01 – 2024-09-30
−USD 10.15 million
Exact value

Exact value: -10151556 USD

2023-10-01 – 2024-09-30: -10151556 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 8.46 million
Exact value

Exact value: -8464146 USD

2023-10-01 – 2024-09-30: -8464146 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 1.7 million
Exact value

Exact value: 1700000 USD

2023-10-01 – 2024-09-30: 1700000 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 10.16 million
Calculation and evidence

-8464146 − 1700000 USD

Exact free cash flow: -10164146 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

2025 2024-10-01 – 2025-09-30
−USD 40.07 million
Exact value

Exact value: -40067076 USD

2024-10-01 – 2025-09-30: -40067076 USD Inspect Net Income Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 19.62 million
Exact value

Exact value: -19621963 USD

2024-10-01 – 2025-09-30: -19621963 USD Inspect Operating Cash Flow Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

USD 8.45 million
Exact value

Exact value: 8449332 USD

2024-10-01 – 2025-09-30: 8449332 USD Inspect Capital Expenditure Open source
Share or cite

The citation records this snapshot. The page link may show a newer release later.

−USD 28.07 million
Calculation and evidence

-19621963 − 8449332 USD

Exact free cash flow: -28071295 USD

Share or cite

The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

17 filings · 593 latest values · 593 originally reported values

Dataset published . Source filing dates and reporting periods are shown separately.

Identifiers: 0001923891, 1923891, NNE, edgar:1923891

Also known as NANO NUCLEAR ENERGY INC., NANO NUCLEAR ENERGY INC., Nano Nuclear Energy, Inc., Nano Nuclear Energy Inc., Nano Nuclear Energy, Inc.